Skip to main content
Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
255.55
-9.60 (-3.62%)
Apr 29, 2026, 4:20 PM CET

Novo Nordisk Revenue

In the year 2025, Novo Nordisk had annual revenue of 309.06B DKK with 6.43% growth. Novo Nordisk had revenue of 79.14B in the quarter ending December 31, 2025, a decrease of -7.63%.

Revenue
309.06B
Revenue Growth
+6.43%
P/S Ratio
3.80
Revenue / Employee
4.47M
Employees
69,505
Market Cap
1,175.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025309.06B18.66B6.43%
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Genmab 23.66B
Coloplast 27.89B
ALK-Abelló 6.31B
Demant 22.97B
H. Lundbeck 24.63B
Zealand Pharma 9.21B
Ambu A/S 6.09B
Bavarian Nordic 6.24B
Revenue Rankings

Novo Nordisk News

More News